Carregant...
Pharmacokinetics of Alemtuzumab in Pediatric Patients Undergoing ex vivo T-Cell Depleted Haploidentical Hematopoietic Cell Transplantation
PURPOSE: Alemtuzumab is a humanized monoclonal antibody against CD52 which is predominantly present on T- and B-lymphocytes. Alemtuzumab has been used as part of conditioning regimens for prophylaxis against rejection and GVHD. While the mechanism of action is well-understood, the pharmacokinetics o...
Guardat en:
| Publicat a: | Cancer Chemother Pharmacol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7735192/ https://ncbi.nlm.nih.gov/pubmed/33037919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-020-04160-7 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|